High level delegation from USFDA visits Divi's Labs Choutuppal facility
Advertisement
Hyderabad: Divi's Laboratories Limited has announced that a high-level delegation from the U.S. Food and Drug Administration (USFDA), including Commissioner Dr. Robert M. Califf, India Country Director Dr. Sarah McMullen, and other officials, visited the company's manufacturing facility in Choutuppal, Telangana, India.
The delegation's visit covered a wide range of topics, reflecting the dynamic landscape of the Active Pharmaceutical Ingredient (API) industry, the integration of new technologies, sustainable practices in chemistry, raising manufacturing standards, and ensuring the availability of APIs.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.